Jorge A. Tavel

3.6k citations

43 papers · 2.5k indexed · 1 hit paper · h-index 21

Co-authors: H. Clifford Lane Henry Masur Rong Deng Julia A. Metcalf Richard T. Davey Mauricio Maia Michael A. Derby Tracy Burgess
Topics: HIV Research and Treatment (19 papers)HIV/AIDS Research and Interventions (13 papers)HIV-related health complications and treatments (10 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: The Journal of Experimental Medicine Blood PLoS ONE
Partner nations: United States Australia United Kingdom

In The Last Decade

Jorge A. Tavel

43 papers receiving 2.4k citations

Hit Papers

align trajectories

Peers

Countries citing papers authored by Jorge A. Tavel

Since Specialization

Citations

This map shows the geographic impact of Jorge A. Tavel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge A. Tavel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge A. Tavel more than expected).

Fields of papers citing papers by Jorge A. Tavel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge A. Tavel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge A. Tavel. The network helps show where Jorge A. Tavel may publish in the future.

Co-authorship network of co-authors of Jorge A. Tavel

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge A. Tavel. A scholar is included among the top collaborators of Jorge A. Tavel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge A. Tavel. Jorge A. Tavel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized trial comparing concise and standard consent forms in the START trial 2017 ·PLoS ONE ·Christine Grady,Giota Touloumi,A. Sarah Walker,Mary Smolskis,Shweta Sharma,Abdel G. Babiker,Nikos Pantazis,Jorge A. Tavel,Éric Florence,Adriana Sánchez,Fleur Hudson,Antonios Papadopoulos,Ezekiel J. Emanuel,(unknown),David J. Munroe,Eileen Denning,(unknown)	22
2	Pharmacokinetics of MHAA4549A, an Anti-Influenza A Monoclonal Antibody, in Healthy Subjects Challenged with Influenza A Virus in a Phase IIa Randomized Trial 2017 ·Clinical Pharmacokinetics ·Rong Deng,(unknown),Mauricio Maia,Jeremy J. Lim,Tracy Burgess,(unknown),Michael A. Derby,Elizabeth M. Newton,Jorge A. Tavel,William D. Hanley	22
3	Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease 2012 ·PLoS ONE ·(unknown),Jorge A. Tavel,(unknown),(unknown),Jing Qin,(unknown),Xiao Liu,Dean Follmann,Julia A. Metcalf,Susan Orsega,(unknown),James D. Neaton,H. Clifford Lane,(unknown)	78
4	Interferon-α Produces Significant Decreases in HIV Load 2010 ·Journal of Interferon & Cytokine Research ·Jorge A. Tavel,Chiung‐Yu Huang,(unknown),Julia A. Metcalf,Robin Dewar,Akram Shah,M. B. Vasudevachari,Dean Follmann,Betsey Herpin,Richard T. Davey,Michael A. Polis,Joseph A. Kovacs,Henry Masur,H. Clifford Lane	33
5	Effects of Intermittent IL-2 Alone or with Peri-Cycle Antiretroviral Therapy in Early HIV Infection: The STALWART Study 2010 ·PLoS ONE ·Jorge A. Tavel,(unknown)	13
6	Development and Implementation of Clinical Trial Protocol Templates at the National Institute of Allergy and Infectious Diseases 2009 ·Clinical Trials ·(unknown),Mary Smolskis,Peter J. Bianchine,Dennis O. Dixon,(unknown),Betsey Herpin,Jorge A. Tavel	2
7	The Effect of Continuous Versus Pericycle Antiretroviral Therapy on IL-2 Responsiveness 2008 ·Journal of Interferon & Cytokine Research ·(unknown),Barbara Hahn,Catherine Rehm,Joseph W. Adelsberger,Jing Qin,Dean Follmann,Jorge A. Tavel,Joseph A. Kovacs,Irini Sereti,Richard T. Davey	1
8	CD4⁺T Cell Responses to Interleukin‐2 Administration in HIV‐Infected Patients Are Directly Related to the Baseline Level of Immune Activation 2007 ·The Journal of Infectious Diseases ·Irini Sereti,Peter Sklar,Meena S. Ramchandani,Sarah W. Read,Vinay K. Aggarwal,Hiromi Imamichi,Ven Natarajan,Julia A. Metcalf,Joseph A. Kovacs,Jorge A. Tavel,Richard T. Davey,Rebecca DerSimonian,H. Clifford Lane	10
9	Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans 2007 ·Blood ·Norihisa Sakamoto,Kazuhide Tsuji,Linda Muul,Ann M. Lawler,Emanuel F. Petricoin,Fabio Candotti,Julia A. Metcalf,Jorge A. Tavel,H. Clifford Lane,Walter J. Urba,Bernard A. Fox,Ajit Varki,Joan K. Lunney,Amy S. Rosenberg	43
10	Post-trial Access to Tested Interventions: The Views of IRB/REC Chair, Investigators, and Research Participants in a Multinational HIV/AIDS Study 2006 ·AIDS Research and Human Retroviruses ·Christine A. Pace,Christine Grady,David Wendler,Judith D. Bebchuk,Jorge A. Tavel,(unknown),(unknown),Jack Killen,Ezekiel J. Emanuel	16
11	Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals 2005 ·Human Gene Therapy ·Richard A. Morgan,Robert Walker,Charles S. Carter,Ven Natarajan,Jorge A. Tavel,(unknown),(unknown),Linda Muul,(unknown),Shyla Jagannatha,Bruce A. Bunnell,Vicki Fellowes,Julia A. Metcalf,Randy Stevens,Michael Baseler,Susan F. Leitman,Elizabeth J. Read,R. Michael Blaese,H. Clifford Lane	2
12	Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals 2005 ·Human Gene Therapy ·Richard A. Morgan,Robert Walker,Charles S. Carter,Ven Natarajan,Jorge A. Tavel,(unknown),(unknown),Linda Muul,Zhili Zheng,Shyla Jagannatha,Bruce A. Bunnell,Vicki Fellowes,Julia A. Metcalf,Randy Stevens,Michael Baseler,Susan F. Leitman,Elizabeth J. Read,R. Michael Blaese,H. Clifford Lane	55
13	CD4 Cell Response to 3 Doses of Subcutaneous Interleukin 2: Meta-analysis of 3 Vanguard Studies 2004 ·Clinical Infectious Diseases ·Roberto C. Arduino,Esteban C. Nannini,(unknown),Shannon Schrader,Marcelo Losso,Kiat Ruxrungtham,Maria C. Allende,Sean Emery,Lisa Fosdick,James D. Neaton,Jorge A. Tavel,Richard T. Davey,H. Clifford Lane,(unknown)	31
14	Antiretroviral Drug Content in Products from Developing Countries 2004 ·Clinical Infectious Diseases ·Scott Penzak,Edward P. Acosta,Maria L. Turner,Jorge A. Tavel,Henry Masur	9
15	A Randomized, Double‐Blinded, Placebo‐Controlled Trial of Intermittent Administration of Interleukin‐2 and Prednisone in Subjects Infected with Human Immunodeficiency Virus 2003 ·The Journal of Infectious Diseases ·Jorge A. Tavel,Irini Sereti,Robert Walker,Barbara Hahn,Joseph A. Kovacs,Shyla Jagannatha,Richard T. Davey,Judith Falloon,Michael A. Polis,Henry Masur,Julia A. Metcalf,Randy Stevens,Adam Rupert,Michael Baseler,H. Clifford Lane	12
16	Regulatory approvals in a large multinational clinical trial 2002 ·Controlled Clinical Trials ·(unknown),Jorge A. Tavel,(unknown),(unknown),(unknown),Judith D. Bebchuk,(unknown)	11
17	Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV 2001 ·The Journal of Experimental Medicine ·Joseph A. Kovacs,Richard A. Lempicki,Igor A. Sidorov,Joseph W. Adelsberger,Betsey Herpin,Julia A. Metcalf,Irini Sereti,Michael A. Polis,Richard T. Davey,Jorge A. Tavel,Judith Falloon,Randy Stevens,(unknown),Robin Dewar,Douglas J. Schwartzentruber,Miriam R. Anver,Michael Baseler,Henry Masur,Dimiter S. Dimitrov,H. Clifford Lane	181
18	Ongoing trials of immune-based therapies for HIV infection in adults 2001 ·Expert Opinion on Biological Therapy ·Robert W. Ross,Mary E. Wright,Jorge A. Tavel	5
19	A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand 2000 ·AIDS ·Kiat Ruxrungtham,Surapol Suwanagool,Jorge A. Tavel,(unknown),Eugène Kroon,Sasiwimol Ubolyam,Supranee Buranapraditkun,(unknown),(unknown),Sean Emery,Richard T. Davey,Lisa Fosdick,Chaiyos Kunanusont,H. Clifford Lane,Praphan Phanuphak	30
20	Guide to Major Clinical Trials of Antiretroviral Therapy in Human Immunodeficiency Virus‐Infected Patients: Protease Inhibitors, Non‐Nucleoside Reverse Transcriptase Inhibitors, and Nucleotide Reverse Transcriptase Inhibitors 1999 ·Clinical Infectious Diseases ·Jorge A. Tavel,Kirk D. Miller,Henry Masur	34

About Jorge A. Tavel

Jorge A. Tavel is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 43 papers that have together received 2.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (19 papers), HIV/AIDS Research and Interventions (13 papers) and HIV-related health complications and treatments (10 papers). The work is most often cited by research in Virology (453 citations), Infectious Diseases (440 citations) and Immunology (393 citations). Jorge A. Tavel has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include H. Clifford Lane, Henry Masur, Rong Deng, Julia A. Metcalf, Richard T. Davey, Mauricio Maia, Michael A. Derby, Tracy Burgess, Joseph A. Kovacs and Michael A. Polis. Their work appears in journals such as The Journal of Experimental Medicine, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact